Bill Sponsors: US HB7640 | 2021-2022 | 117th Congress

Bill Title: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7640 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialFinancialEncyclopediaBiographyBioGuide
Representative Gus Bilirakis [R]PrimarySponsored BillsHD-FL-12OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative G. Butterfield [D]CosponsorSponsored BillsHD-NC-1OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Social Comments on US HB7640

feedback